KATHERINE DAVIS
TECHNOLOGY & HEALTH CARE JOURNALIST
Cardiovascular Business
Although heart diseases can affect anyone, a new study shows evidence that a certain string of heart failures occur more often in minority athletes than their atheltic counerparts of different races and genders.
Anger and hostility can have harmful affects on one’s cardiovascular health, but the color of your skin may determine how severe that impact will be.
Highly anticipated research on Abbott Vascular’s bioresorbable coronary stent was revealed over the weekend, and results were a bit underwhelming for cardiologists who hoped it would outperform metallic stents.
AliveCor has introduced Kardia Pro, a cloud-based software platform that allows physicians to monitor patients who use the corresponding mobile electrocardiogram (ECG), Kardia Mobile.
A coalition of medical centers in southeast Michigan have found a way to increase the survival rate of cardiogenic shock patients to 84 percent by using a heart pump manufactured by Danvers, Massachusetts-based Abiomed.
Researchers at the Universities of Michigan and Texas found that race has an impact on smoking patterns among cigarette users in the U.S., and who will be more successful in efforts to quit the addictive habit.
After going from No. 25 to No. 6 in a U.S. News and World Report ranking in just six years, Northwestern University’s cardiology department and cardiothoracic surgery programs have grown increasingly competitive among leading cardiovascular centers across the country.
Two new trials on eluting heart stents designed to treat unprotected left main coronary artery disease were presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2016 conference, and they have left cardiologists stumped over their conflicting findings.
Research from the University of Louisville has found that the Abiomed Impella 2.5 heart pump helps reduce the risk of acute kidney injury—even in patients with preexisting kidney disease—when physicians are trying to complete a high-risk percutaneous coronary intervention (HRPCI).
A significant advancement was made this week in cardiovascular care for patients suffering from heart problems.
A major problem cardiologists face when treating diabetic patients is getting them to adhere to treatment programs. With many patients quitting suggested treatment within weeks and months, physicians are constantly looking for methods to help keep patients on track.
New findings on Medtronic’s drug-filled stent (DFS) were unveiled this week at the annual Transcatheter Cardiovascular Therapeutics (TCT) 2016 conference that suggest metallic stents are still being improved and won’t be phased out anytime soon.
Diversity in the workplace remains a challenge for many industries around the nation. But when physicians are treating patients with vein, artery and heart conditions, a diverse staff can play an important role when connecting with and giving patients of all backgrounds the best care possible.
Mountain View, California-based AliveCor, which makes the personal electrocardiogram, Kardia Mobile, has plans to enhance the device with a new detection feature through a collaboration with Mayo Clinic.